Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

Go to Regulatory Recap News

Subscribe for Weekly Updates

The Advocacy &  Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.

Subscribe

Alaska Updates Medical Fee Schedule

In a February 19th special meeting, the Board approved new rules and addressed confusion regarding resource materials

Read More →

February 23, 2026

Claim Data

California Reports That COVID-19 Drove Recent Increases in Injury and Illness

Using data from the Bureau of Labor Statistics, the CWCI found that COVID-19 drove recent increases in injury and illness, with rates decreasing lately.

Read More →

February 23, 2026

Access to Care Ancillary Services

Oregon Extends Sign Language Interpreter Licensing Pause

Prolonged licensure pauses risk reducing interpreter availability and disrupting access to care.

Read More →

February 23, 2026

Advocacy Opportunity Treatment Guidelines

Tennessee Medical Advisory Committee Meeting Recap

The meeting covered potential updates to treatment guidelines, specifically for physical therapy, as well as other topics.

Read More →

February 16, 2026

Technology

More States Continue to Introduce AI Healthcare Bills

Colorado, Georgia, Iowa, Illinois, and Rhode Island have introduced new bills, joining a growing national movement.

Read More →

February 16, 2026

Marijuana

Kansas Introduces Medical Marijuana Bill

The 115-page bill details qualifying conditions, registration processes, regulation boards, taxes, and much more.

Read More →

February 16, 2026

Mental Health Pharmacy Data

California Publishes Report on Psychotherapeutic and Neurological Drugs

While this drug class represents less than 1% of prescriptions, it accounted for 3.4% of drug spend.

Read More →

February 16, 2026

Billing & Payments Claims Procedures Treatment Guidelines

Georgia Introduces Prescription Drug Reform Bill

The bill would allow payers to direct prescriptions to pharmacy networks and create limits for physician dispensing and compounds.

Read More →

February 9, 2026

Access to Care Claims Procedures

Arizona Bill Could Expand Worker Choice in Medical Care

Senate Bill 1404 could grant workers greater choice over their provider, pharmacy, certain ancillary services, and more.

Read More →

February 9, 2026

« Previous 1 … 13 14 15 16 17 … 59 Next »

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.

hello world!

Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Expert Q&A: Cybersecurity Tactics in Workers’ Compensation

RxInformer editors sat down with Healthesystems’ AVP of Information Security and resident cybersecurity expert, Tony Brown, to discuss how cyber threats affect workers’ comp organizations.

Drug Pricing Legislation and Its Impact on Workers' Comp

Lawmakers look to regulate the U.S. drug supply chain in ways that could impact workers’ comp pharmacy management.

High Prices, High Impact: Meet the Drugs Driving Up Claim Costs in Workers’ Comp

High-impact drugs, including topicals and compounds, represent proportionately low utilization compared to opioids or NSAIDs, but they can increase pharmacy spend exponentially on impacted claims.